← All trials
NCT05059106
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2021
- Primary completion
- Jun 1, 2022
- Completion date
- Oct 30, 2022
- First posted
- Sep 28, 2021
- Last posted
- Sep 28, 2021
- Enrollment
- 29637
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Federal University of Espirito SantoLead sponsor
- Federal University of Espirito SantoReponsible party - principal investigator
- Federal University of Minas GeraisCollaborator
- Escola Nacional de Saúde Pública Sérgio Arouca/FiocruzCollaborator
- Escola Superior de Ciências da Santa Casa de Misericórdia de VitóriaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.